MALARIA FALCIPARUM

This early-stage study is testing the safety and immune response of a new malaria vaccine in healthy adults and young children in Burkina Faso. Researchers are giving different combinations of vaccine components to small groups to see which is safest and most promising. The goal …

This large trial is testing a new strategy to control a type of malaria that can hide in the liver and cause repeat infections. Researchers will use a blood test to find people who were recently infected, then give them a targeted drug treatment to kill the hidden parasites. The …

This study aims to see if giving malaria medicine to everyone in a community, regardless of whether they feel sick, can drastically cut down on malaria infections and stop the disease from spreading. It will involve about 9,000 people in Ghana and compare a new two-drug combinati…

This is the first study in humans to test the safety of a new oral drug called GSK4024484, which is being developed to treat falciparum malaria. The trial will enroll 156 healthy adult volunteers to see how their bodies handle single and multiple doses of the drug, and whether ta…

This study is testing if finding and treating malaria very early in pregnancy can prevent serious problems for newborns. It will compare a new strategy—using a highly sensitive malaria test in the first three months of pregnancy—against standard prenatal care. The goal is to see …